Are you on the hunt for new portfolio additions in July? If you are, it could be worth hearing what analysts are recommending this week, courtesy of The Bull.
Here are three ASX shares that have been named as buys:
Image source: Getty Images
BHP Group Ltd (ASX: BHP)
Catapult Wealth thinks that investors should be considering this mining giant. It has named BHP shares as a buy this week.
The wealth management firm highlights strong copper prices, a robust balance sheet, and an attractive dividend yield as reasons to buy. It said:
The global miner holds dominant positions in iron ore and copper and is leveraged to increasing demand during the energy transition. A review of the Jansen stage 2 potash project in Canada resulted in a cost blowout of about $US2 billion to $US6.9 billion. Despite the Jansen impairment and the risk of industrial action at iron ore operations in the Pilbara region of Western Australia, near term earnings momentum remains strong.
Elevated copper prices and strong iron ore prices supported performance in full year 2026. The balance sheet remains robust with low net debt, while a recent dividend yield above 3 per cent adds income appeal. BHP offers cyclical upside and long term growth exposure to copper.
Dexus Convenience Retail REIT (ASX: DXC)
Another ASX share that is rated positively is Dexus Convenience Retail REIT. It offers service station and convenience retail assets exposure.
Sanlam Private Wealth has named its shares as a buy, highlighting its cheap valuation and big dividend yield. It said:
This real estate investment trust owns service stations and convenience retail assets, mostly on Australia's eastern seaboard. The fund's portfolio was valued at about $760 million on December 31, 2025. The company was recently trading at a significant discount to net tangible assets (NTA) and was yielding about 8 per cent. The trust has an attractive development pipeline, modest debt and recently increased its buy-back target.
Importantly, the NTA is supported by recent asset sales of 1.5 per cent above valuation. Recently announced capital gains tax changes make the company's assets appealing to self-managed super funds looking for reliable income generating assets. DXC is a solid defensive play in the current environment.
ResMed Inc. (ASX: RMD)
The team at Catapult Wealth is also bullish on this sleep disorder treatment company. This week, it has named ResMed shares as a buy.
The wealth management firm likes the company due to its defensive qualities and positive growth outlook. It said:
ResMed is a global leader in sleep apnoea devices and digital health platforms, benefiting from strong structural demand and resilient clinical positioning. Despite the progression in GLP-1 therapies for treating sleep apnoea, ResMed's CPAP (continuous positive airway pressure) treatments remain superior at this point in time. RMD continues to offer appealing growth, income and defensive healthcare exposure.
